ABSENOR

Main information

  • Trade name:
  • ABSENOR 300 mg gastro-resistant tablet
  • Dosage:
  • 300 mg
  • Pharmaceutical form:
  • gastro-resistant tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ABSENOR 300 mg gastro-resistant tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Valproic acid
  • Product summary:
  • Previous_names: DEPRAKINE; Suitability for use in older adult patients Natrii valproas Suitable for older persons, with specific cautions. Sedative. Low albumin level in serum increases the response. Several adverse effects, such as changes in blood count and risk of hepatic injury.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 6376
  • Authorization date:
  • 03-03-2010
  • Last update:
  • 26-07-2018